Bioequivalence: Stereochemical Considerations

References

• Bio International 89. TorontoCanada October 1–4, 1989
   Google Scholar
• Analytical Method Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies Conference. ArlingtonVA, USA December 3–5, 1990
   Google Scholar
• International Harmonization & Consensus Meeting on Bioavailability & Bioequivalence Testing Requirement and Standards. BarcelonaSpain March 18–20, 1991
   Google Scholar
• Bio International. FrankfurtGermany May 20–22, 1992
   Google Scholar
• From Controversy to Resolution: Bioequivalence of Racemic Drugs. Atlanta, GAUSA October 14–16, 1991
   Google Scholar
• Jamali F., Mehvar R., Pasutto F. Enantioselective drug action and disposition: Therapeutic pitfalls. J Phann Sci. 1989; 78: 695–715
   PubMed Web of Science ®Google Scholar
• Caldwell J. The importance of stereochemistry in drug action and disposition. J Clin Pharmacol 1992, In press
   PubMed Web of Science ®Google Scholar
• Ariens E. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol. 1984; 26: 663–668
   PubMed Web of Science ®Google Scholar
• Shah V., Midha K., Dighe S., McGilveray I., Skelly J., Yacobi A., Layloff T., Viswanathan C., Cook C., McDowall R., Pittman K., Spector S. Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies. Pharm Res. 1992; 9: 588–592
   Web of Science ®Google Scholar
• Good Laboratory Practice Regulations. Department of Health and Human Services, FDA, US Federal Register. 1978, Anonymous
   Google Scholar
• Balant L. Is there a need for more precise definitions of bioavailability. Eur J Clin Pharmacol. 1991; 40: 123–126
   PubMed Web of Science ®Google Scholar
• Ariens E. Racemic therapeutics - ethical and regulatory aspects. Eur J Clin Pharmacol. 1991; 41: 89–93
   PubMed Web of Science ®Google Scholar
• Wright M., Jamali F. Methods for the analysis of enantiomers of racemic drugs: Application to pharmacokinetic and pharmacological studies. J Phamol Methods 1992, Submitted to
   Google Scholar
• Duddu S., Vakily M., Jamali F., Grant D. Interaction of chiral drugs with chiral excipient: Stereoselective dissolution of propranolol HCl from matrices containing hydroxypropylmethylcellulose. Pharm Res 1992, Submitted to
   PubMedGoogle Scholar
• Lee E., Williams K., Day R., Graham G., Champion D. Stereoselective disposition of ibuprofen enantiomers in man. Br J Clin Pharmacol. 1985; 19: 669–674
   PubMed Web of Science ®Google Scholar
• Jamali F., Mehvar R., Russell A., Sattari S., Yakimets W., Koo J. Human pharmacokinetics of ibuprofen enantiomers following different doses and formulations: Intestinal chid inversion. J Pharm Sci. 1992; 81: 221–225
   PubMed Web of Science ®Google Scholar
• Borin M., Cox S., Hageman J., Szpunar G. Serum concentrations of ibuprofen enantiomers following multiple dose administration of sustained release ibuprofen 800 mg tablets. Pharm Res. 1988; 5: 15
   Google Scholar
• Walker S., Hardy B. (1991) Alteration in apparent bioequivalency of ibuprofen based on isomer analysis. Presented to the American College of Clinical Pharmacology meeting, Atlanta, GA, October, 14–161991, 7–8
   Google Scholar
• Hutt A., Caldwell J. The importance of stereochemistry in the clinical pharmacokinetics of the 2-arylpropionic acid non-steroidal anti-inflammatory drugs. Clin Phamokin. 1984; 9: 371–373
   PubMed Web of Science ®Google Scholar
• Eichelbaum M. Pharmacokinetic and pharmacodynamic consequences of stereoselective drug metabolism in man. Biochem Phannacol. 1988; 37: 93–96
   PubMed Web of Science ®Google Scholar
• Sahajwalla C., Longstreth J., Karim A., Punch E., Cabana B. (1991) Consequences in pooling R-+ S-verapamil in bioequivalence assessment. Presented to the American College of Clinical Pharmacology meeting, Atlanta, GA, October, 14–161991, 14–15
   Google Scholar
• Sahajwalla C., Longstreth J., Karim A., El-Shourbagy T., Vetticaden S., Punch E., Malone D., Cabana B. (1991) Bioavailability-bioequivalence of Calan SR, Verapamil SR and Calan IR based on R-, S-, and R,-verapamil. Presented to the American College of Clinical Pharmacology meeting, Atlanta, GA, October, 14–161991, 15–16
   Google Scholar
• Singh N., Jamali F., Pasutto F., Coutts R. Stereoselective gas-chromatographic analysis of etodolac enantiomers in human plasma and urine. J Chromatogr. 1986; 312: 331–337
   Google Scholar
• Jamali F. Enantioselective aspects of pharmacokinetics: therapeutic implications. Pharmacocinetique: de la recherche a la cliniaue, J. Bres, G. Panis. John Libbey Eurotext. 1992; 11–16
   Google Scholar
• Jamali F., Collins D., Berry B., Molder S., Cheung R., McColl K., Cheung H. Comparative bioavailability of two flurbiprofen products: Stereospecific versus conventional approach. Biophann Drug Dispos. 1991; 12: 435–445
   PubMed Web of Science ®Google Scholar
• Jamali F. Stereochemistry and bioequivalence. J Clin Phannacol. 1992, In press
   Google Scholar
• Averginos A., Noormohammadi A., Hutt A. Disposition of ibuprofen following administration of a novel controlled release formulation to healthy volunteers. Znt J Phann. 1991; 68: 97–103
   Web of Science ®Google Scholar
• Donnelly R., Macphee G. Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol. Clin Phannacokin. 1991; 21: 95–109
   PubMed Web of Science ®Google Scholar
• Some views from the Medical Products Agency on the documentation for chid drugs. Registration Division. Medical Product Agency, UppsalaSweden 1991, Anonymous
   Google Scholar